Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients

Metformin, the first-line drug in type 2 diabetes mellitus, elicits cardiovascular protection also in obese patients via pleiotropic effects, among which the anti-oxidant is one of the most investigated. The aim of the present study was to assess whether metformin can acutely mitigate oxidative stre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lascu, Ana, Ionică, Loredana-Nicoleta, Merce, Adrian-Petru, Dănilă, Maria-Daniela, Petrescu, Lucian, Sturza, Adrian, Muntean, Danina-Mirela, Streian, Caius Glad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785172/
https://www.ncbi.nlm.nih.gov/pubmed/36556423
http://dx.doi.org/10.3390/life12122058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785172/
https://www.ncbi.nlm.nih.gov/pubmed/36556423
http://dx.doi.org/10.3390/life12122058

Ejemplares similares